Toronto-based Intrepid Labs, which we profiled a year ago, has closed an Avant Bio-backed $7 million seed round, bringing its total financing to over $11 million. The company’s Valiant platform is an autonomous lab technology that pairs machine-learning algorithms with robotics to potentially explore up to 1 billion possible formulations. It aims to cut drug-product design…
Intrepid Labs’ self-driving lab reimagines drug formulation
The pharma industry has long relied on tried-and-true drug formulation approaches sometimes rooted in trial and error, but this reliance on the familiar has created a bottleneck in the development of new and better medicines. University of Toronto Professor Christine Allen, Ph.D., co-founder and CEO of Toronto-based Intrepid Labs, points out that the traditional drug…